Business Unusual

When unicorns lose their horns

In the technology startup world 90% of projects will fail but investors can’t be sure which will be the one to succeed. When one does, the investment spikes, setting up expectations that a unicorn has been born.

Unicorns are exciting (or at least appear that way) and get lots of media coverage which adds to the hype (See the Hype Cycle) and attracts both those that want to help by getting a job or looking to find if they could copy the idea and try do the same.

Here is the story of a unicorn that may survive the current difficult period or will in time be shown to have never been an actual unicorn in the first place.

Theranos

A medical company that could run over 200 blood tests using the blood drawn from a pin prick and have the results in minutes sounds more like science fiction that fact (more on a tricorder below).

Theranos, a privately-owned medical company, set out to do that and with a $9 billion valuation appeared to have created something amazing. But tests have shown that the results are not as accurate as they needed to be.

The CEO, founder and 50% owner Elizabeth Holmes (32 in 2016), is the youngest female self-made billionaire.

She is an American and was a great student wanting to pursue medicine from early on. She lived for a time in China with her parents and then worked on a bird flu project in Singapore. She had a fear of needles and opted to pursue chemical engineering instead of medicine.

While studying at Stanford University she founded Theranos in 2003 at age 19. She left her studies to pursue the idea of doing extensive blood testing with a process that needed only a fraction of the usual volume of blood and much less time.

The device, called Edison, attracted significant investment (over $400 million, some reports say over $700 million) and partnerships with large companies to manage the blood testing on their behalf.

Holmes and Theranos have 100 patents on their methods and appeared to build on their breakthroughs to capture a significant segment of the medical testing market.

Then, in October 2015, the Wall Street Journal reported that the FDA had carried out an inspection that found the device was inaccurate and only approved its use for one test. It said that the rest of the tests msut be performed using traditional testing systems.

Since then there has been more bad news in the form of a criminal probe to determine if the device is able to do what it claims. The supposed technology and patents have existed for more than a decade now so it is understandable that research papers on the effectiveness and means for doing the tests should be made available (at least to authorities and the scientific community). However, none are currently available.

It would either appear that this unicorn has lost its horn or it is battling a very tough period that one investor claims is motivated by competitors wanting to limit the disruption to the industry.

If it can survive the challenges to its credibility, and demonstrate that it can do the tests accurately with just a pin prick's worth of blood, then Theranos will go on to become as well known as Google and Apple and make Elizabeth Holmes one of the richest people on the planet.

If not, it would serve as a footnote that progress is messy and that medicine, in particular, has had a tough time overcoming challenges to our health.

Time will tell, but as fewer and fewer unicorns are being discovered, venture capital is becoming more circumspect about how it will use the capital. It is significantly down from its high point at the end of 2015. It might mean a slow down for disruption as access to significant capital is a critical part for new start-ups to challenge the incumbents.

Tricorder x Prize

Star Trek fans will recall a device used to determine what was wrong with anyone without touching them. Qualcomm offered $10 million to anyone that could design a device to mimic Dr McCoy's trusted tricorder. It launched in 2013 with 312 teams registering, In May last year that was reduced to seven finalists. The winner will be announced early in 2017 and, assuming the device works, medicine would have boldly gone where no-one had gone before.


Recommended

by NEWSROOM AI
Read More
Electric scooters - transport revolution or fad? It's probably both

Electric scooters - transport revolution or fad? It's probably both

You might not look good, but you will have fun, and you won’t be using a car.

Fortnite - two weeks will never be the same again

Fortnite - two weeks will never be the same again

The deathmatch game that may be the last one standing.

How three letters could save the planet from climate change

How three letters could save the planet from climate change

You might not like it, but the world's best scientists think a tax is the best way to deal with climate change.

Super economies may sound great, but they also create super losers

Super economies may sound great, but they also create super losers

How technology created the superstar but killed the profession.

How flavour created the modern economy

How flavour created the modern economy

A look at how our desire for spice changed the world and how it continues to do so.

The businesses that boomed and went bust on Business Unusual

The businesses that boomed and went bust on Business Unusual

Predictions, products and personalities featured in "Business Unusual" in the last three years.

Popular articles
Gigaba implicated in Transnet impropriety

Gigaba implicated in Transnet impropriety

Gigaba has been fingered in a forensic investigation related to the procurement process for locomotives from China South Rail.

[LISTEN] Cervical cancer is the only cancer that is caused by sex - Dr Eve

[LISTEN] Cervical cancer is the only cancer that is caused by sex - Dr Eve

Dr Eve discusses cervical cancer and how it can be prevented.

[LISTEN] Is Gqom really music? Callers share their views

[LISTEN] Is Gqom really music? Callers share their views

Callers on the open line discuss class appropriation by musicians and music genres.

Angry customer stops at nothing to expose bad service at upmarket hotel

Angry customer stops at nothing to expose bad service at upmarket hotel

Khabazela shares some of the most popular tweets, posts, and videos on 'What's gone Viral'.

3 risks to your retirement savings (and how to mitigate each of them)

3 risks to your retirement savings (and how to mitigate each of them)

Only 5% of South African retirement fund members will retire comfortably. Bruce Whitfield interviews advisor Warren Ingram.

Gift of the Givers' Dr Imtiaz Sooliman – angel amongst men – talks about money

Gift of the Givers' Dr Imtiaz Sooliman – angel amongst men – talks about money

"I have no desire for clothes. I have no desire for holidays. I have no desire for outings. All I see is the suffering of people…"

Gauteng Education to do away with old apartheid era feeder schools policy

Gauteng Education to do away with old apartheid era feeder schools policy

The new feeder policies will be implemented by 2020.

Discovery Bank takes on Capitec Bank, TymeDigital (Patrice Motsepe), Bank Zero

Discovery Bank takes on Capitec Bank, TymeDigital (Patrice Motsepe), Bank Zero

South Africa has a brand-new bank! The Money Show’s Bruce Whitfield interviews Adrian Gore, Discovery Group CEO.